Retail News

Image description

WSJ: FDA inspection scuttles Theranos' Zika-virus emergency clearance request

Theranos is facing its latest crisis following its withdrawal of its request for emergency clearance of a Zika-virus blood test after federal regulators found that the company didn’t include proper patient safeguards in a study of the new test, The Wall Street Journal reported Tuesday, citing people familiar with the matter. "Theranos founder Elizabeth Holmes announced Aug. 1 a new blood-testing device called miniLab that she said was designed for use outside a clinical laboratory and could run accurate tests from a few drops of blood," The Journal wrote. "But during an inspection by the FDA earlier this month, regulators concluded that Theranos had collected some data supporting the accuracy of the Zika test without implementing a patient-safety protocol approved by an institutional review board." (The Wall Street Journal)

Image description

Report: Cardinal Health acquires telepharmacy to enhance in-house pharmacy services

DUBLIN, Ohio — Accoding to a report published Monday in The Columbus Dispatch, Cardinal Health has purchased TelePharm, a firm that offers secure Internet-based pharmacy services such as prescription approval. A Cardinal spokesman told The Dispatch that the company "will work with the TelePharm leadership team to identify opportunities to integrate the technology" with existing services Cardinal offers to pharmacies. (The Columbus Dispatch)